Stock screenerAll disclosures →
EDGAR →
AQST
Conviction 38HealthcareScan · Mon, Aug 10, 2026AQST$4.29+8.88%
ResistanceSupportVol 14Insider sellVol MA14 2.66M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price4.29
Change+8.88%
Gap+11.04%
Rel volume5.27×
Avg volume2.38M
Avg $ vol9.34M
SMA 203.87
SMA 504.10
SMA 2004.60
Price vs 50+4.66%
Price vs 200-6.74%
MA stackmixed
50/200 cross—
Supertrendup · 3.74
RSI (14)62
MACD hist0.06
MACD crossbull · 2d
Stoch %K / %D68 / 66
ADX (14)18
+DI / −DI33 / 12
RSI divergence—
MACD divergenceBullish
ATR %+5.26%
ADR %5.13%
52w high7.49
52w low2.95
From 52w high-42.72%
Above 52w low+45.42%
New 52w highNo
SqueezeOff
Bollinger width17.40%
%B1.13
Donchian pos68.22%
Donchian high4.63
Donchian low3.56
AVWAP (52w high)4.52
vs AVWAP high-5.11%
AVWAP (52w low)4.11
vs AVWAP low+4.46%
OBV trendUp
Chaikin MF (20)-0.21
Today vs 20d5.27×
Avg vol (14d)2.66M
Avg vol (20d)2.38M
Avg $ vol (20d)9.34M
Market cap—
RS 3m (vs SPY)-12.55%
RS 6m (vs SPY)-11.51%
RS line new highNo
Trend template2/8
Technical rank57.6
1 week+13.19%
1 month+4.13%
3 months-0.69%
6 months+4.38%
1 year+9.16%
YTD-33.49%
P/E-5.91
P/B-14.53
P/S11.11
P/FCF-9.34
EPS-0.7800
Div yield—
ROE246.03%
ROA-59.37%
Debt/Eq-1.32
Current4.10
EV/EBITDA-6.32
Gross margin—
Net margin-188.09%
Rev growth-22.61%
EPS growth-89.83%
Price target8.57
Target upside117.24%
Analyst ratingBuy
Institutional63.63%
Ent. value429.17M
Revenue14.45M
Net income-8.06M
Gross profit—
Free cash flow-52.99M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.45M
Employees147
ListedWed, Jul 25, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank57.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.78
Support3.69
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AQST
No recent disclosed trades by Congress in AQST. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AQST · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Barber Daniel President and CEO · Common Stock · 2026-07-16 | Sell | 20.37K | $82K | 2026-07-16 | 2026-07-17 |
Barber Daniel President and CEO · Common Stock · 2026-07-15 | Sell | 4.63K | $19K | 2026-07-15 | 2026-07-17 |
Krop Julie Director · Common Stock · 2026-06-23 | Exercise | 25K | $18K | 2026-06-23 | 2026-06-24 |
Krop Julie Director · Common Stock · 2026-06-23 | Sell | 25K | $125K | 2026-06-23 | 2026-06-24 |
Krop Julie Director · Non-Qualified Stock Option (right to buy) · 2026-06-23 | Exercise | 25K | — | 2026-06-23 | 2026-06-24 |
Barber Daniel President and CEO · Common Stock · 2026-06-15 | Sell | 25K | $104K | 2026-06-15 | 2026-06-16 |
BROWN GREGORY B Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
Taglietti Marco Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
Cochran John Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
Jenkins Abigail L. Director · Non-Qualified Stock Option (right to buy) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
SEC filings
EDGAR filings in AQST · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.